ArticleDiagnostics (Basel, Switzerland)2021

Feasibility Study on Using Dynamic Contrast Enhanced MRI to Assess the Effect of Tyrosine Kinase Inhibitor Therapy within the STAR Trial of Metastatic Renal Cell Cancer.

Jim Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.